000 01225 a2200361 4500
005 20250517215416.0
264 0 _c20181002
008 201810s 0 0 eng d
022 _a1752-1947
024 7 _a10.1186/s13256-018-1580-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBelai, Natnael
245 0 0 _aHydrochlorothiazide and risk of hearing disorder: a case series.
_h[electronic resource]
260 _bJournal of medical case reports
_cMay 2018
300 _a135 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAged
650 0 4 _aAntihypertensive Agents
_xadverse effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHearing Loss
_xchemically induced
650 0 4 _aHumans
650 0 4 _aHydrochlorothiazide
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTime Factors
700 1 _aGebrehiwet, Selamawit
700 1 _aFitsum, Yodit
700 1 _aRussom, Mulugeta
773 0 _tJournal of medical case reports
_gvol. 12
_gno. 1
_gp. 135
856 4 0 _uhttps://doi.org/10.1186/s13256-018-1580-8
_zAvailable from publisher's website
999 _c28407717
_d28407717